Didox (3,4-dihydroxybenzohydroxamic acid) reduces the vascular inflammation induced by acute intravascular hemolysis

Blood Cells Mol Dis. 2020 Mar:81:102404. doi: 10.1016/j.bcmd.2020.102404. Epub 2020 Jan 11.

Affiliations

¹ Hematology Center, University of Campinas-UNICAMP, Brazil.
² Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota Medical School, MN, USA.
³ Molecules for Health, Inc., 800 East Leigh Street, Suite 206-4, Richmond, VA 23219, USA.
⁴ Hematology Center, University of Campinas-UNICAMP, Brazil. Electronic address: conran@unicamp.br.

PMID: 31972517
DOI: 10.1016/j.bcmd.2020.102404

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Blood Vessels / pathology*
Hemolysis*
Humans
Hydroxamic Acids / therapeutic use*
Inflammation / drug therapy*
Inflammation / etiology

Substances

Hydroxamic Acids
3,4-dihydroxybenzohydroxamic acid